Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last Decade
Sign Up to like & getrecommendations! Published in 2022 at "Genes"
DOI: 10.3390/genes13081426
Abstract: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease, characterized by the specific loss of dopaminergic neurons in the midbrain. The pathophysiology of PD is likely caused by a variety of environmental and hereditary… read more here.
Keywords: disease; parkinson disease; lrrk2; development lrrk2 ... See more keywords